Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference

–ARIKAYCE® (amikacin liposome inhalation suspension) Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of…Read More